Fifty years devoted to anaerobes: historical, lessons, and highlights
Renew interest and enthusiasm for anaerobes stem from both technological improvements (culture media, production of an adequate anaerobic atmosphere, identification methods) and greater awareness on the part of clinicians. Anaerobic infections were historically treated empirically, targeting the spe...
Gespeichert in:
Veröffentlicht in: | European journal of clinical microbiology & infectious diseases 2024, Vol.43 (1), p.1-15 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 15 |
---|---|
container_issue | 1 |
container_start_page | 1 |
container_title | European journal of clinical microbiology & infectious diseases |
container_volume | 43 |
creator | Dubreuil, Luc J. |
description | Renew interest and enthusiasm for anaerobes stem from both technological improvements (culture media, production of an adequate anaerobic atmosphere, identification methods) and greater awareness on the part of clinicians. Anaerobic infections were historically treated empirically, targeting the species known to be involved in each type of infection.
Prevotella
, fusobacteria, and Gram-positive cocci (GPAC) were considered responsible for infections above the diaphragm whereas for intra-abdominal infections,
Bacteroides
of the
fragilis
group (BFG), GPAC and clostridia were predominantly implicated. The antibiotic susceptibility of anaerobes was only taken into consideration by the clinician in the event of treatment failure or when faced with infections by multidrug-resistant bacteria (MDR). The evolution of antibiotic resistance together with clinical failures due to the absence of detection of hetero-resistant clones has resulted in a greater need for accessible antibiotic susceptibility testing (AST) and disc diffusion method. Improved isolation and identification of anaerobes, along with the availability of accessible and robust methods for performing AST, will ensure that treatment, whether empirical or guided by an antibiogram, will lead to better outcomes for anaerobic infections. |
doi_str_mv | 10.1007/s10096-023-04708-4 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2891750105</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2891750105</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-9c4344661cf3db21bb654d964c58ecb3012cd605df6c87d8bad4e628048c08e73</originalsourceid><addsrcrecordid>eNp9kDtPwzAUhS0EouXxBxhQJBaGBvyKH2yoagGpEgvMVmI7bao0Lr4pUv89hhaQGBiu73C-c651ELog-IZgLG8hvVrkmLIcc4lVzg_QkHBW5JxJdoiGWDOea0nZAJ0ALHEyKSmP0YBJLZnQbIgm06but9nWlxEy599D713Wh6zsSh9D5eEuWzTQh9jYsh1lrQcIHYyS7pIwX7RpejhDR3XZgj_f71P0Op28jB_z2fPD0_h-llsmiz7XljPOhSC2Zq6ipKpEwZ0W3BbK24phQq0TuHC1sEo6VZWOe0EV5spi5SU7Rde73HUMbxsPvVk1YH3blp0PGzBUaSILTHCR0Ks_6DJsYpd-Z6gmRFCqNU4U3VE2BoDoa7OOzaqMW0Ow-SzZ7Eo2qWTzVbLhyXS5j95UK-9-LN-tJoDtAEhSN_fx9_Y_sR_8joYZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2911622990</pqid></control><display><type>article</type><title>Fifty years devoted to anaerobes: historical, lessons, and highlights</title><source>Springer Nature - Complete Springer Journals</source><creator>Dubreuil, Luc J.</creator><creatorcontrib>Dubreuil, Luc J.</creatorcontrib><description>Renew interest and enthusiasm for anaerobes stem from both technological improvements (culture media, production of an adequate anaerobic atmosphere, identification methods) and greater awareness on the part of clinicians. Anaerobic infections were historically treated empirically, targeting the species known to be involved in each type of infection.
Prevotella
, fusobacteria, and Gram-positive cocci (GPAC) were considered responsible for infections above the diaphragm whereas for intra-abdominal infections,
Bacteroides
of the
fragilis
group (BFG), GPAC and clostridia were predominantly implicated. The antibiotic susceptibility of anaerobes was only taken into consideration by the clinician in the event of treatment failure or when faced with infections by multidrug-resistant bacteria (MDR). The evolution of antibiotic resistance together with clinical failures due to the absence of detection of hetero-resistant clones has resulted in a greater need for accessible antibiotic susceptibility testing (AST) and disc diffusion method. Improved isolation and identification of anaerobes, along with the availability of accessible and robust methods for performing AST, will ensure that treatment, whether empirical or guided by an antibiogram, will lead to better outcomes for anaerobic infections.</description><identifier>ISSN: 0934-9723</identifier><identifier>EISSN: 1435-4373</identifier><identifier>DOI: 10.1007/s10096-023-04708-4</identifier><identifier>PMID: 37973693</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Accessibility ; Anaerobes ; Anaerobic treatment ; Antibiotic resistance ; Antibiotics ; Biomedical and Life Sciences ; Biomedicine ; Culture media ; Diaphragm ; Gram-positive cocci ; Identification methods ; Infections ; Internal Medicine ; Medical Microbiology ; Multidrug resistance ; Review</subject><ispartof>European journal of clinical microbiology & infectious diseases, 2024, Vol.43 (1), p.1-15</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-9c4344661cf3db21bb654d964c58ecb3012cd605df6c87d8bad4e628048c08e73</citedby><cites>FETCH-LOGICAL-c375t-9c4344661cf3db21bb654d964c58ecb3012cd605df6c87d8bad4e628048c08e73</cites><orcidid>0000-0001-6814-8739</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10096-023-04708-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10096-023-04708-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51298</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37973693$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dubreuil, Luc J.</creatorcontrib><title>Fifty years devoted to anaerobes: historical, lessons, and highlights</title><title>European journal of clinical microbiology & infectious diseases</title><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><description>Renew interest and enthusiasm for anaerobes stem from both technological improvements (culture media, production of an adequate anaerobic atmosphere, identification methods) and greater awareness on the part of clinicians. Anaerobic infections were historically treated empirically, targeting the species known to be involved in each type of infection.
Prevotella
, fusobacteria, and Gram-positive cocci (GPAC) were considered responsible for infections above the diaphragm whereas for intra-abdominal infections,
Bacteroides
of the
fragilis
group (BFG), GPAC and clostridia were predominantly implicated. The antibiotic susceptibility of anaerobes was only taken into consideration by the clinician in the event of treatment failure or when faced with infections by multidrug-resistant bacteria (MDR). The evolution of antibiotic resistance together with clinical failures due to the absence of detection of hetero-resistant clones has resulted in a greater need for accessible antibiotic susceptibility testing (AST) and disc diffusion method. Improved isolation and identification of anaerobes, along with the availability of accessible and robust methods for performing AST, will ensure that treatment, whether empirical or guided by an antibiogram, will lead to better outcomes for anaerobic infections.</description><subject>Accessibility</subject><subject>Anaerobes</subject><subject>Anaerobic treatment</subject><subject>Antibiotic resistance</subject><subject>Antibiotics</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Culture media</subject><subject>Diaphragm</subject><subject>Gram-positive cocci</subject><subject>Identification methods</subject><subject>Infections</subject><subject>Internal Medicine</subject><subject>Medical Microbiology</subject><subject>Multidrug resistance</subject><subject>Review</subject><issn>0934-9723</issn><issn>1435-4373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kDtPwzAUhS0EouXxBxhQJBaGBvyKH2yoagGpEgvMVmI7bao0Lr4pUv89hhaQGBiu73C-c651ELog-IZgLG8hvVrkmLIcc4lVzg_QkHBW5JxJdoiGWDOea0nZAJ0ALHEyKSmP0YBJLZnQbIgm06but9nWlxEy599D713Wh6zsSh9D5eEuWzTQh9jYsh1lrQcIHYyS7pIwX7RpejhDR3XZgj_f71P0Op28jB_z2fPD0_h-llsmiz7XljPOhSC2Zq6ipKpEwZ0W3BbK24phQq0TuHC1sEo6VZWOe0EV5spi5SU7Rde73HUMbxsPvVk1YH3blp0PGzBUaSILTHCR0Ks_6DJsYpd-Z6gmRFCqNU4U3VE2BoDoa7OOzaqMW0Ow-SzZ7Eo2qWTzVbLhyXS5j95UK-9-LN-tJoDtAEhSN_fx9_Y_sR_8joYZ</recordid><startdate>2024</startdate><enddate>2024</enddate><creator>Dubreuil, Luc J.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6814-8739</orcidid></search><sort><creationdate>2024</creationdate><title>Fifty years devoted to anaerobes: historical, lessons, and highlights</title><author>Dubreuil, Luc J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-9c4344661cf3db21bb654d964c58ecb3012cd605df6c87d8bad4e628048c08e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Accessibility</topic><topic>Anaerobes</topic><topic>Anaerobic treatment</topic><topic>Antibiotic resistance</topic><topic>Antibiotics</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Culture media</topic><topic>Diaphragm</topic><topic>Gram-positive cocci</topic><topic>Identification methods</topic><topic>Infections</topic><topic>Internal Medicine</topic><topic>Medical Microbiology</topic><topic>Multidrug resistance</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dubreuil, Luc J.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of clinical microbiology & infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dubreuil, Luc J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fifty years devoted to anaerobes: historical, lessons, and highlights</atitle><jtitle>European journal of clinical microbiology & infectious diseases</jtitle><stitle>Eur J Clin Microbiol Infect Dis</stitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><date>2024</date><risdate>2024</risdate><volume>43</volume><issue>1</issue><spage>1</spage><epage>15</epage><pages>1-15</pages><issn>0934-9723</issn><eissn>1435-4373</eissn><abstract>Renew interest and enthusiasm for anaerobes stem from both technological improvements (culture media, production of an adequate anaerobic atmosphere, identification methods) and greater awareness on the part of clinicians. Anaerobic infections were historically treated empirically, targeting the species known to be involved in each type of infection.
Prevotella
, fusobacteria, and Gram-positive cocci (GPAC) were considered responsible for infections above the diaphragm whereas for intra-abdominal infections,
Bacteroides
of the
fragilis
group (BFG), GPAC and clostridia were predominantly implicated. The antibiotic susceptibility of anaerobes was only taken into consideration by the clinician in the event of treatment failure or when faced with infections by multidrug-resistant bacteria (MDR). The evolution of antibiotic resistance together with clinical failures due to the absence of detection of hetero-resistant clones has resulted in a greater need for accessible antibiotic susceptibility testing (AST) and disc diffusion method. Improved isolation and identification of anaerobes, along with the availability of accessible and robust methods for performing AST, will ensure that treatment, whether empirical or guided by an antibiogram, will lead to better outcomes for anaerobic infections.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>37973693</pmid><doi>10.1007/s10096-023-04708-4</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0001-6814-8739</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0934-9723 |
ispartof | European journal of clinical microbiology & infectious diseases, 2024, Vol.43 (1), p.1-15 |
issn | 0934-9723 1435-4373 |
language | eng |
recordid | cdi_proquest_miscellaneous_2891750105 |
source | Springer Nature - Complete Springer Journals |
subjects | Accessibility Anaerobes Anaerobic treatment Antibiotic resistance Antibiotics Biomedical and Life Sciences Biomedicine Culture media Diaphragm Gram-positive cocci Identification methods Infections Internal Medicine Medical Microbiology Multidrug resistance Review |
title | Fifty years devoted to anaerobes: historical, lessons, and highlights |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T02%3A08%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fifty%20years%20devoted%20to%20anaerobes:%20historical,%20lessons,%20and%20highlights&rft.jtitle=European%20journal%20of%20clinical%20microbiology%20&%20infectious%20diseases&rft.au=Dubreuil,%20Luc%20J.&rft.date=2024&rft.volume=43&rft.issue=1&rft.spage=1&rft.epage=15&rft.pages=1-15&rft.issn=0934-9723&rft.eissn=1435-4373&rft_id=info:doi/10.1007/s10096-023-04708-4&rft_dat=%3Cproquest_cross%3E2891750105%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2911622990&rft_id=info:pmid/37973693&rfr_iscdi=true |